Metabolic Research

Cagrilintide

Name: Cagrilintide
Brand: Ventra Sciences
Availability: InStock

CAS 1415456-99-3 Research Use Only

An amylin analog research peptide studied in appetite-signaling and satiety research. For laboratory research use only.

Dosage

Quantity

$65.00

Bundle & save

Free priority shipping on $250+

Third-party tested

U.S.-synthesized & shipped

Discreet packaging

Free Amino H2O on orders $150+

Compound Information

Technical specifications

Molecular Profile

What is this compound?

Type: Long-acting amylin analog
CAS Number: 1415456-99-3
Molecular Weight: 4409.01 g/mol
Formula: C194H312N54O59S2
Amino Acids: 38

PubChem Database

Storage Requirements

Stability Information

Protect from light Temperature-sensitive

Lyophilized (powder) -20°C · stable long-term

Reconstituted 2-8°C · use within 28 days

Sources & References

Peer-reviewed research

New England Journal of Medicine

Coadministered Cagrilintide and [GLP-1-S] in Adults with Overweight or Obesity

2025 PMID 40544433 DOI 10.1056/NEJMoa2502081

Garvey WT, Blüher M, Osorto Contreras CK, et al.

View on PubMed

The Lancet

Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly [GLP-1-S] 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

2023 PMID 37364590 DOI 10.1016/S0140-6736(23)01163-7

Frias JP, Deenadayalan S, Erichsen L, et al.

View on PubMed

The Lancet

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

2021 PMID 34798060 DOI 10.1016/S0140-6736(21)01751-7

Lau DCW, Erichsen L, Francisco AM, et al.

View on PubMed

References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.

Cagrilintide is a long-acting amylin analog studied in appetite-signaling, satiety, and metabolic research.

Product Description

Cagrilintide - 5 mg

For In Vitro Research Use Only – Not for Human or Veterinary Application

Specifications:

Quantity: 5 mg
Form: Lyophilized Powder

Intended Use:

This compound is intended strictly for in vitro laboratory research by qualified professionals.
It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or
cosmetics.

Disclaimer:

This compound has not been evaluated by the FDA.
It is not intended to diagnose, treat, cure, or prevent any disease.
All use must comply with applicable institutional, local, and federal regulations.

Terms of Sale:

By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or
institution.
All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory
compliance.

Research applications: Commonly paired with GLP-1 agonists in combination metabolic research protocols.

For laboratory research use only. Not a drug, cosmetic, supplement, or food. Not for human or animal consumption.

This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.